EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre

Edgar L Poon, Hyang Joo Lim, Samantha A Hollingworth, Mieke L van Driel, David M Pache, Geraldine M Moses, Treasure M McGuire

The Journal of Primary Health Care · 30.06.2022 · 14 (2) · 99-108

DOI: 10.1071/hc21150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Primary Health Care, online erschienen am 22.04.2022. Verfasst von Edgar L Poon und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, The University of Queensland, Brisbane, Qld, Australia; and Mater Pharmacy, Mater Health South East Queenland, Brisbane, Qld, Aus…. Hauptthemen laut MEDLINE: Call Centers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antidepressant use has increased over the last two decades, with Australia and New Zealand among the highest antidepressant users in Organisation for Economic Co-operation and Development (OECD) countries. Comorbidity and polypharmacy are common in antidepressant users, increasing the likelihood of interaction-related adverse drug events, which are frequently preventable.

Aim

We aimed to identify, profile, and analyse potential antidepressant drug–drug interactions in information-seeking antidepressant users.

Methods

We retrospectively analysed antidepressant-related drug–drug interaction enquiries from patients or carers who contacted a pharmacist-led Australian national medicines call centre over an 8-year period to determine patient characteristics, concomitant drugs involved, prevalence and type of antidepressant-related drug–drug interaction across life stages, and associated risks.

Results

Of 3899 antidepressant drug–drug interaction calls, the most frequent concomitant drugs were antipsychotics, opioids, benzodiazepines, and complementary medicines. Narrative analyses of 2011 calls identified 81.0% of patients with potential drug–drug interactions and 10.4% categorised with worrying symptoms. The most frequent drug–drug interaction risks were excessive sedation, increased anticholinergic effects, serotonin syndrome, and suicidal thoughts. Carers of children aged <15 years and older adults (65–74 years) were more likely to report experiencing worrying symptoms. Although more potential pharmacodynamic than pharmacokinetic interactions were recorded, pharmacokinetic interactions tended to have more significant clinical impact.

Discussion

Antidepressant users often have information gaps and safety concerns regarding drug–drug interactions that motivate help-seeking behaviour. Symptoms and drug–drug interaction consequences may be underestimated in these patients. Primary care health professionals have a role in proactively addressing the risk of drug–drug interactions to support benefit-risk assessment and shared decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Call CentersAntidepressive AgentsAustraliaChildHumansPolypharmacyRetrospective Studies

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • School of Pharmacy, The University of Queensland, Brisbane, Qld, Australia; and Mater Pharmacy, Mater Health South East Queenland, Brisbane, Qld, Australia; and Greenslopes Private Hospital, Ramsay Health, Brisbane, Qld…
  • School of Pharmacy, The University of Queensland, Brisbane, Qld, Australia.
  • Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia.
  • School of Pharmacy, The University of Queensland, Brisbane, Qld, Australia; and Mater Pharmacy, Mater Health South East Queenland, Brisbane, Qld, Australia; and Faculty of Health Sciences and Medicine, Bond University,…
  • School of Pharmacy, The University of Queensland, Brisbane, Qld, Australia; and Mater Pharmacy, Mater Health South East Queenland, Brisbane, Qld, Australia.

Zitieren

APA

Poon, E. L., Lim, H. J., Hollingworth, S. A., van Driel, M. L., Pache, D. M., Moses, G. M., & McGuire, T. M. (2022). Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre. The Journal of Primary Health Care, 14(2), 99-108. https://doi.org/10.1071/hc21150

Vancouver

Poon EL, Lim HJ, Hollingworth SA, van Driel ML, Pache DM, Moses GM, et al. Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre. The Journal of Primary Health Care. 2022;14(2):99-108. doi:10.1071/hc21150

BibTeX
@article{Poon2022,
  author = {Poon, Edgar L and Lim, Hyang Joo and Hollingworth, Samantha A and van Driel, Mieke L and Pache, David M and Moses, Geraldine M and McGuire, Treasure M},
  title = {Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre},
  journal = {The Journal of Primary Health Care},
  year = {2022},
  volume = {14},
  number = {2},
  pages = {99--108},
  doi = {10.1071/hc21150}
}
Kostenlos starten →